INDEX vs. FMED

Last updated Apr 2, 2026

Compare and contrast key facts about Index Funds S&P 500 Equal Weight (INDEX) and Fidelity Disruptive Medicine ETF (FMED).

INDEX is managed by Fidelity. It was launched on Mar 9, 2017. FMED is an actively managed fund by Fidelity. It was launched on Apr 16, 2020.

Performance

INDEX vs. FMED - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Index Funds S&P 500 Equal Weight (INDEX) and Fidelity Disruptive Medicine ETF (FMED). The values are adjusted to include any dividend payments, if applicable.

INDEX vs. FMED - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
INDEX Index Funds S&P 500 Equal Weight	-4.43%	17.77%	24.73%	6.37%
FMED Fidelity Disruptive Medicine ETF	-8.72%	9.69%	2.29%	-4.20%

Returns By Period

In the year-to-date period, INDEX achieves a -4.43% return, which is significantly higher than FMED's -8.72% return.

INDEX

• 1D: 2.93%
• 1M: -5.02%
• YTD: -4.43%
• 6M: -2.12%
• 1Y: 17.21%
• 3Y*: 14.62%
• 5Y*: 9.46%
• 10Y*: 11.68%

FMED

• 1D: 0.50%
• 1M: -5.09%
• YTD: -8.72%
• 6M: -1.81%
• 1Y: 6.64%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

INDEX vs. FMED - Expense Ratio Comparison

INDEX has a 0.25% expense ratio, which is lower than FMED's 0.50% expense ratio.

FMED

Fidelity Disruptive Medicine ETF

INDEX

Index Funds S&P 500 Equal Weight

Return for Risk

INDEX vs. FMED — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INDEX

INDEX Risk / Return Rank: 59
INDEX Sharpe Ratio Rank: 47
INDEX Sortino Ratio Rank: 53
INDEX Omega Ratio Rank: 55
INDEX Calmar Ratio Rank: 63
INDEX Martin Ratio Rank: 75

FMED

FMED Risk / Return Rank: 18
FMED Sharpe Ratio Rank: 19
FMED Sortino Ratio Rank: 21
FMED Omega Ratio Rank: 19
FMED Calmar Ratio Rank: 16
FMED Martin Ratio Rank: 17

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

INDEX vs. FMED - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Index Funds S&P 500 Equal Weight (INDEX) and Fidelity Disruptive Medicine ETF (FMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	INDEX	FMED	Difference
Sharpe ratio Return per unit of total volatility	0.97	0.31	+0.65
Sortino ratio Return per unit of downside risk	1.49	0.61	+0.88
Omega ratio Gain probability vs. loss probability	1.23	1.07	+0.16
Calmar ratio Return relative to maximum drawdown	1.51	0.25	+1.26
Martin ratio Return relative to average drawdown	7.28	0.77	+6.51
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

INDEX vs. FMED - Sharpe Ratio Comparison

The current INDEX Sharpe Ratio is 0.97, which is higher than the FMED Sharpe Ratio of 0.31. The chart below compares the historical Sharpe Ratios of INDEX and FMED, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	INDEX	FMED	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.97	0.31	+0.65
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.57	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.63	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.55	-0.04	+0.59

Correlation

The correlation between INDEX and FMED is 0.64, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Dividends

INDEX vs. FMED - Dividend Comparison

INDEX's dividend yield for the trailing twelve months is around 1.09%, while FMED has not paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
INDEX Index Funds S&P 500 Equal Weight	1.09%	1.04%	1.97%	1.56%	3.25%	1.81%	1.53%	1.61%	3.09%	1.15%
FMED Fidelity Disruptive Medicine ETF	0.00%	0.00%	0.46%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

INDEX vs. FMED - Drawdown Comparison

The maximum INDEX drawdown since its inception was -38.82%, which is greater than FMED's maximum drawdown of -21.84%. Use the drawdown chart below to compare losses from any high point for INDEX and FMED.

Drawdown Indicators

	INDEX	FMED	Difference
Max Drawdown Largest peak-to-trough decline	-38.82%	-21.84%	-16.98%
Max Drawdown (1Y) Largest decline over 1 year	-12.10%	-18.33%	+6.23%
Max Drawdown (5Y) Largest decline over 5 years	-21.52%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-38.82%	—	—
Current Drawdown Current decline from peak	-6.26%	-14.38%	+8.12%
Average Drawdown Average peak-to-trough decline	-4.69%	-6.65%	+1.96%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.52%	5.96%	-3.44%

Volatility

INDEX vs. FMED - Volatility Comparison

The current volatility for Index Funds S&P 500 Equal Weight (INDEX) is 5.35%, while Fidelity Disruptive Medicine ETF (FMED) has a volatility of 8.13%. This indicates that INDEX experiences smaller price fluctuations and is considered to be less risky than FMED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	INDEX	FMED	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.35%	8.13%	-2.78%
Volatility (6M) Calculated over the trailing 6-month period	9.48%	13.94%	-4.46%
Volatility (1Y) Calculated over the trailing 1-year period	18.28%	21.32%	-3.04%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	16.76%	18.30%	-1.54%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	18.65%	18.30%	+0.35%